Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
Acetylcysteine
|
Generic
Brand Dose Administration Clinical Indications Mode of Action Adverse Effects Assessment |
|
Albuterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Aminophylline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Atropine
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Beclomethasone dipropionate
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Beclomethasone dipropionate HFA
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Bitolterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Budesonide
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Cromolyn Sodium
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Dornase Alfa
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Dyphylline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Epinephrine
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Ethyl Alcohol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Flunisolide
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Fluticasone propionate
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Fluticasone propionate/salmeterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Formoterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Hypertonic Saline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Hypotonic Saline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Ipratropium and Albuterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Ipratropium bromide
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Isoetharine
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Isoproterenol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Levalbuterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Metaproterenol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Nedocromil Sodium
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Normal Saline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Oxtriphylline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Pentamidine Isethionate
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Pirbuterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Racemic Epinephrine
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Ribavirin
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Salmeterol
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Sodium Bicarbonate
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Terbutaline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Theophyline
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Tiotropium Bromide
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Tobramycin
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Triamcinolone acetonide
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |
|
Zanamivir
|
Generic
Brand Dose Administration Clinical Indications Mode of Actions Adverse Effects Assessment |